News
PharmAust (ASX: PAA) has changed its name to Neurizon Therapeutics - NUZ (ASX: NUZ).
Below are the previous articles from PharmAust (ASX: PAA):
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Immuron chalks up record half for travelers’ diarrhoea medicine, Travelan
News
In Case You Missed It: Lithium, chocolate and an IVF tech distribution deal
Health & Biotech
PharmAust just got a pre-IND meeting with the US FDA to kick off ‘24
News
In Case You Missed It: A plethora of acquisitions in the works and some tungsten
Health & Biotech
Up to $1.8m funding from motor neurone disease foundation could be on the table for PharmAust
News
In Case You Missed It: Lithium, tyre recycling and copper-gold drilling
Health & Biotech
Santa (and ATO) delivers PharmAust $550k cash boost for Christmas
News
In Case You Missed It: A new iron ore MD and an $8.8bn pharmacy merger
Health & Biotech
Prominent Perth fundie the main backer in PharmAust’s $3.5m cap raise
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: The ASX is spectacularly flat on Monday
News
In Case You Missed It: A lithium project acquisition and a West African gold and lithium hunt
Health & Biotech
PharmAust bolsters leadership as CEO attends global ALS/MND Symposium
News
In Case You Missed It: A Chilean silver mine and $1m worth of lithium rights
Health & Biotech
PharmAust completes Phase 1 motor neurone disease trial, applies for Orphan Drug Designation
Health & Biotech
“Market is going to be surprised” as Firebrick Pharma set to launch antiviral nasal spray, Nasodine
Health & Biotech
